Lupin informs about press release

10 Dec 2018 Evaluate

Lupin has informed about submission of a Press Release as regards receipt of 'Establishment Inspection Report' from the USFDA, at the company's Pithampur (Unit 3) (Indore) facility. This is a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

1683.50 23.55 (1.42%)
21-May-2024 15:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.00
Dr. Reddys Lab 5780.70
Cipla 1442.00
Zydus Lifesciences 1088.45
Lupin 1683.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.